Yoshikazu Ishii

InstitutionToho University School of Medicine
AddressTokyo
Japan
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 8 Covid-19 publications, with a maximum of 3 publications in December 2020
    All Publications
    Bar chart showing 176 publications over 21 distinct years, with a maximum of 13 publications in 2005
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Aoki K, Takai K, Nagasawa T, Kashiwagi K, Mori N, Matsubayashi K, Satake M, Tanaka I, Kodama N, Shimodaira T, Ishii Y, Miyazaki T, Ishii T, Morita T, Yoshimura T, Tateda K. Combination of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Diagnosis. Ann Lab Med. 2021 Nov 01; 41(6):568-576. PMID: 34108284.
      Citations: 4     Fields:    Translation:Humans
    2. Maeda T, Kashiwagi K, Yoshizawa S, Sato T, Aoki K, Ishii Y, Tateda K. Early Anti-SARS-CoV-2 Immunoglobulin G Response May Be Associated with Disease Severity in Patients with COVID-19. Jpn J Infect Dis. 2021 Nov 22; 74(6):560-562. PMID: 33642431.
      Citations:    Fields:    Translation:Humans
    3. Ishii T, Sasaki M, Yamada K, Kato D, Osuka H, Aoki K, Morita T, Ishii Y, Tateda K. Immunochromatography and chemiluminescent enzyme immunoassay for COVID-19 diagnosis. J Infect Chemother. 2021 Jun; 27(6):915-918. PMID: 33676843.
      Citations: 4     Fields:    Translation:Humans
    4. Uema M, Yonemitsu K, Momose Y, Ishii Y, Tateda K, Inoue T, Asakura H. Effect of the Photocatalyst under Visible Light Irradiation in SARS-CoV-2 Stability on an Abiotic Surface. Biocontrol Sci. 2021; 26(2):119-125. PMID: 34092715.
      Citations:    Fields:    Translation:HumansCells
    5. Aoki K, Nagasawa T, Ishii Y, Yagi S, Kashiwagi K, Miyazaki T, Tateda K. Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2. J Infect Chemother. 2021 Feb; 27(2):319-322. PMID: 33388232.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    6. Kashiwagi K, Ishii Y, Aoki K, Yagi S, Maeda T, Miyazaki T, Yoshizawa S, Aoyagi K, Tateda K. Immunochromatographic test for the detection of SARS-CoV-2 in saliva. J Infect Chemother. 2021 Feb; 27(2):384-386. PMID: 33397587.
      Citations: 7     Fields:    Translation:Humans
    7. Aoki K, Nagasawa T, Ishii Y, Yagi S, Okuma S, Kashiwagi K, Maeda T, Miyazaki T, Yoshizawa S, Tateda K. Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs. J Infect Chemother. 2021 Apr; 27(4):613-616. PMID: 33423918.
      Citations: 14     Fields:    Translation:Humans
    8. Kashiwagi K, Maeda T, Yoshizawa S, Sato T, Aoki K, Ishii Y, Tateda K. IgG Antibodies, SARS-CoV-2 Load, and Prognostic Indicators in Patients with Severe and Mild COVID-19 in Japan. J Nippon Med Sch. 2021 Sep 01; 88(4):380-383. PMID: 33250476.
      Citations:    Fields:    Translation:Humans